The effect of recombinant human erythropoietin on the treatment of anemia of prematurity;O efeito da eritropoetina humana recombinante no tratamento da anemia da prematuridade

Jornal de Pediatria

Volumn 77, Issue 2, 2001, Pages 75-83

  Rocha, V L L ^a   Benjamin, A C W ^a   Procianoy, R S ^a  

^a NONE   (Brazil)

Author keywords

Anemia of prematurity; Erythropoietin; Premature; Transfusion

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ARTICLE; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HOSPITALIZATION; HUMAN; NEWBORN; NEWBORN ANEMIA; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

EID: 0034967778     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.180     Document Type: Article

References (37)

1. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity
2. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity
3. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study
4. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level
5. The anemia of prematurity factors governing the erythropoietin response
6. Neonatal anemia: Pathophysiology and treatment
7. Use of recombinant erythropoietin in treatment of the anemia of prematurity
8. Pathophysiology and treatment of the anemia of prematurity
9. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity
10. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized controlled study
11. Changing patterns of red blood cell transfusion in very low birth weight infants
12. Decreased response of plasma immunoreactive erythropoietin to "avaiable oxygen" in anemia of prematurity
13. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity"
14. Neonatal anemia: Pathophysiology and treatment
15. Prediction of the need for transfusion during anemia of prematurity
16. Effect of high doses of human recombinant erythropoietin on the infants for blood transfusions in preterm infants
17. Tratamiento com eritropoyetina humana recombinante en período neonatal: Indicaciones y controversias
18. Erythropoietin in the neonate
19. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity"
20. Circulating erythroid progenitors in the anemia of prematurity
21. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study
22. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity European randomized multicenter trial
23. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
24. Erythropoietin therapy in preterm infants
25. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: A randomized trial
26. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity
27. Decrease ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity
28. Enhancement of erythropoiesis by recombinant human erythropoietin in low weight infants: A pilot study
29. Commentary on small-volume red cell transfusions for neonatal patients
30. Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: Effects on serum immunoreactive Epo, growth and protein and iron metabolism
31. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution
32. The role of erythropoietin in the anemia of prematurity
33. Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity
34. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake
35. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin
36. Anemias: General considerations